Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients

Detalhes bibliográficos
Autor(a) principal: Oliveira, Ueriton Dias de
Data de Publicação: 2021
Outros Autores: Santos, Fred Luciano Neves, Castro Filho, Bernardo Galvão, Krieger, Marco Aurelio, Zanchin, Nilson Ivo Tonin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/46391
Resumo: FIOCRUZ Technical Platform program through the Platforms for Protein Purification and Characterization and Proteomics at the Carlos Chagas Institute. This study benefited from FINEP (grant agreement 01.11.0286.00) and BNDES (grant agreement 11.2.1328.1) funding. Nilson I. T. Zanchin is a CNPq research fellow (grants nr. 312195/2015-0 and 304167/2019-3).
id CRUZ_8205afaf1e5c8c2c89d6a39254150e09
oai_identifier_str oai:www.arca.fiocruz.br:icict/46391
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Oliveira, Ueriton Dias deSantos, Fred Luciano NevesCastro Filho, Bernardo GalvãoKrieger, Marco AurelioZanchin, Nilson Ivo Tonin2021-03-22T17:38:58Z2021-03-22T17:38:58Z2021OLIVEIRA, Ueriton Dias de et al. Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients. Journal of Clinical Microbiology, p. 1-43, Jan. 2021.0095-1137https://www.arca.fiocruz.br/handle/icict/4639110.1128/JCM.02701-20FIOCRUZ Technical Platform program through the Platforms for Protein Purification and Characterization and Proteomics at the Carlos Chagas Institute. This study benefited from FINEP (grant agreement 01.11.0286.00) and BNDES (grant agreement 11.2.1328.1) funding. Nilson I. T. Zanchin is a CNPq research fellow (grants nr. 312195/2015-0 and 304167/2019-3).Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Biologia Estrutural e Engenharia de Proteínas. Curitiba, PR, Brasil / Federal University of Paraná. Cellular and Molecular Biology Postgraduate Program. Curitiba, PR, Brazil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório Avançado de Saúde Pública. Salvador, BA, Brasil.Bahiana School of Medicine and Public. Integrated and Multidisciplinary HTLV Center. Salvador, BA, Brazil.Institute of Paraná. Molecular Biology. Curitiba, PR, Brazil.Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Biologia Estrutural e Engenharia de Proteínas. Curitiba, PR, Brasil.HTLV-1 can cause life-threatening diseases for which there are no effective treatments. 32 Prevention of HTLV-1 infection requires massive testing of pregnant women, blood for 33 transfusion and, organs for transplantation as well as safe sex. In this context, serological 34 assays are widely used for monitoring HTLV-1 infections. Despite the necessity of 35 recombinant antigens to compose serological tests, there is little information available on 36 procedures to produce recombinant HTLV1/2 antigens for serological diagnostic purposes. 37 In this work, we tested a series of genetic constructions to select those more amenable for 38 production in bacterial systems. To overcome the constraints to express sections of viral 39 envelope proteins in bacteria, we have used the p24 segment of the gag protein as a 40 scaffold to display the immunogenic regions of gp46 and gp21. Nine recombinant antigenic 41 proteins derived from HTLV-1 and five derived from HTLV-2 were successfully purified. The 42 HTLV-1 antigens showed high efficiency in discriminating HTLV-positive from HTLV43 negative samples using ELISA. Interestingly, HTLV-1-positive samples showed a high level 44 of cross-reaction with HTLV-2 antigens. This finding is explained by the high sequence 45 conservation between the structural proteins of these two highly related viruses. In 46 summary, the results presented in this work provide a detailed description of the methods 47 used to produce recombinant HTLV-1 and HTLV-2 antigens and demonstrate that the 48 HTLV-1 antigens show strong potential for serological diagnosis of HTLV1 infections.engAmerican Society for MicrobiologyVírus Linfotrópico T Tipo 1 HumanoAntígenosPlasmaInfecçãoGestantesHuman Type 1 T Lymphotropic VirusAntigensPlasmaInfectionPregnantsNovel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patientsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83097https://www.arca.fiocruz.br/bitstream/icict/46391/1/license.txt36b51ef91c52b5338d9d29ba0cc807bcMD51ORIGINALOliveira, Ueriton Dias Novel genetic....pdfOliveira, Ueriton Dias Novel genetic....pdfapplication/pdf10488329https://www.arca.fiocruz.br/bitstream/icict/46391/2/Oliveira%2c%20Ueriton%20Dias%20Novel%20genetic....pdf986a4a5bae46c16ad9f36c3a7200f1e1MD52TEXTOliveira, Ueriton Dias Novel genetic....pdf.txtOliveira, Ueriton Dias Novel genetic....pdf.txtExtracted texttext/plain70908https://www.arca.fiocruz.br/bitstream/icict/46391/3/Oliveira%2c%20Ueriton%20Dias%20Novel%20genetic....pdf.txt8584e6b5bbb5d764cb598dd52cec0cc5MD53icict/463912021-03-30 09:34:46.622oai:www.arca.fiocruz.br:icict/46391Q0VTU8ODTyBOw4NPIEVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUw0KDQpBbmEgTWFyaWEgRmlzY2luYSBTYW1wYWlvLCBDUEY6IDA2NS40MzEuMDM1LTE1LCB2aW5jdWxhZG8gYSBDUHFHTSAtIENlbnRybyBkZSBQZXNxdWlzYXMgR29uw6dhbG8gTW9uaXoKCkFvIGFjZWl0YXIgb3MgVEVSTU9TIGUgQ09OREnDh8OVRVMgZGVzdGEgQ0VTU8ODTywgbyBBVVRPUiBlL291IFRJVFVMQVIgZGUgZGlyZWl0b3MKYXV0b3JhaXMgc29icmUgYSBPQlJBIGRlIHF1ZSB0cmF0YSBlc3RlIGRvY3VtZW50bzoKCigxKSBDRURFIGUgVFJBTlNGRVJFLCB0b3RhbCBlIGdyYXR1aXRhbWVudGUsIMOgIEZJT0NSVVogLSBGVU5EQcOHw4NPIE9TV0FMRE8gQ1JVWiwgZW0KY2Fyw6F0ZXIgcGVybWFuZW50ZSwgaXJyZXZvZ8OhdmVsIGUgTsODTyBFWENMVVNJVk8sIHRvZG9zIG9zIGRpcmVpdG9zIHBhdHJpbW9uaWFpcyBOw4NPCkNPTUVSQ0lBSVMgZGUgdXRpbGl6YcOnw6NvIGRhIE9CUkEgYXJ0w61zdGljYSBlL291IGNpZW50w61maWNhIGluZGljYWRhIGFjaW1hLCBpbmNsdXNpdmUgb3MgZGlyZWl0b3MKZGUgdm96IGUgaW1hZ2VtIHZpbmN1bGFkb3Mgw6AgT0JSQSwgZHVyYW50ZSB0b2RvIG8gcHJhem8gZGUgZHVyYcOnw6NvIGRvcyBkaXJlaXRvcyBhdXRvcmFpcywgZW0KcXVhbHF1ZXIgaWRpb21hIGUgZW0gdG9kb3Mgb3MgcGHDrXNlczsKCigyKSBBQ0VJVEEgcXVlIGEgY2Vzc8OjbyB0b3RhbCBuw6NvIGV4Y2x1c2l2YSwgcGVybWFuZW50ZSBlIGlycmV2b2fDoXZlbCBkb3MgZGlyZWl0b3MgYXV0b3JhaXMKcGF0cmltb25pYWlzIG7Do28gY29tZXJjaWFpcyBkZSB1dGlsaXphw6fDo28gZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvIGluY2x1aSwgZXhlbXBsaWZpY2F0aXZhbWVudGUsCm9zIGRpcmVpdG9zIGRlIGRpc3BvbmliaWxpemHDp8OjbyBlIGNvbXVuaWNhw6fDo28gcMO6YmxpY2EgZGEgT0JSQSwgZW0gcXVhbHF1ZXIgbWVpbyBvdSB2ZcOtY3VsbywKaW5jbHVzaXZlIGVtIFJlcG9zaXTDs3Jpb3MgRGlnaXRhaXMsIGJlbSBjb21vIG9zIGRpcmVpdG9zIGRlIHJlcHJvZHXDp8OjbywgZXhpYmnDp8OjbywgZXhlY3XDp8OjbywKZGVjbGFtYcOnw6NvLCByZWNpdGHDp8OjbywgZXhwb3Npw6fDo28sIGFycXVpdmFtZW50bywgaW5jbHVzw6NvIGVtIGJhbmNvIGRlIGRhZG9zLCBwcmVzZXJ2YcOnw6NvLCBkaWZ1c8OjbywKZGlzdHJpYnVpw6fDo28sIGRpdnVsZ2HDp8OjbywgZW1wcsOpc3RpbW8sIHRyYWR1w6fDo28sIGR1YmxhZ2VtLCBsZWdlbmRhZ2VtLCBpbmNsdXPDo28gZW0gbm92YXMgb2JyYXMgb3UKY29sZXTDom5lYXMsIHJldXRpbGl6YcOnw6NvLCBlZGnDp8OjbywgcHJvZHXDp8OjbyBkZSBtYXRlcmlhbCBkaWTDoXRpY28gZSBjdXJzb3Mgb3UgcXVhbHF1ZXIgZm9ybWEgZGUKdXRpbGl6YcOnw6NvIG7Do28gY29tZXJjaWFsOwoKKDMpIFJFQ09OSEVDRSBxdWUgYSBjZXNzw6NvIGFxdWkgZXNwZWNpZmljYWRhIGNvbmNlZGUgw6AgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETwpDUlVaIG8gZGlyZWl0byBkZSBhdXRvcml6YXIgcXVhbHF1ZXIgcGVzc29hIOKAkyBmw61zaWNhIG91IGp1csOtZGljYSwgcMO6YmxpY2Egb3UgcHJpdmFkYSwgbmFjaW9uYWwgb3UKZXN0cmFuZ2VpcmEg4oCTIGEgYWNlc3NhciBlIHV0aWxpemFyIGFtcGxhbWVudGUgYSBPQlJBLCBzZW0gZXhjbHVzaXZpZGFkZSwgcGFyYSBxdWFpc3F1ZXIKZmluYWxpZGFkZXMgbsOjbyBjb21lcmNpYWlzOwoKKDQpIERFQ0xBUkEgcXVlIGEgb2JyYSDDqSBjcmlhw6fDo28gb3JpZ2luYWwgZSBxdWUgw6kgbyB0aXR1bGFyIGRvcyBkaXJlaXRvcyBhcXVpIGNlZGlkb3MgZSBhdXRvcml6YWRvcywKcmVzcG9uc2FiaWxpemFuZG8tc2UgaW50ZWdyYWxtZW50ZSBwZWxvIGNvbnRlw7pkbyBlIG91dHJvcyBlbGVtZW50b3MgcXVlIGZhemVtIHBhcnRlIGRhIE9CUkEsCmluY2x1c2l2ZSBvcyBkaXJlaXRvcyBkZSB2b3ogZSBpbWFnZW0gdmluY3VsYWRvcyDDoCBPQlJBLCBvYnJpZ2FuZG8tc2UgYSBpbmRlbml6YXIgdGVyY2Vpcm9zIHBvcgpkYW5vcywgYmVtIGNvbW8gaW5kZW5pemFyIGUgcmVzc2FyY2lyIGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIGRlCmV2ZW50dWFpcyBkZXNwZXNhcyBxdWUgdmllcmVtIGEgc3Vwb3J0YXIsIGVtIHJhesOjbyBkZSBxdWFscXVlciBvZmVuc2EgYSBkaXJlaXRvcyBhdXRvcmFpcyBvdQpkaXJlaXRvcyBkZSB2b3ogb3UgaW1hZ2VtLCBwcmluY2lwYWxtZW50ZSBubyBxdWUgZGl6IHJlc3BlaXRvIGEgcGzDoWdpbyBlIHZpb2xhw6fDtWVzIGRlIGRpcmVpdG9zOwoKKDUpIEFGSVJNQSBxdWUgY29uaGVjZSBhIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08KT1NXQUxETyBDUlVaIGUgYXMgZGlyZXRyaXplcyBwYXJhIG8gZnVuY2lvbmFtZW50byBkbyByZXBvc2l0w7NyaW8gaW5zdGl0dWNpb25hbCBBUkNBLgoKQSBQb2zDrXRpY2EgSW5zdGl0dWNpb25hbCBkZSBBY2Vzc28gQWJlcnRvIGRhIEZJT0NSVVogLSBGVU5EQcOHw4NPIE9TV0FMRE8gQ1JVWiByZXNlcnZhCmV4Y2x1c2l2YW1lbnRlIGFvIEFVVE9SIG9zIGRpcmVpdG9zIG1vcmFpcyBlIG9zIHVzb3MgY29tZXJjaWFpcyBzb2JyZSBhcyBvYnJhcyBkZSBzdWEgYXV0b3JpYQplL291IHRpdHVsYXJpZGFkZSwgc2VuZG8gb3MgdGVyY2Vpcm9zIHVzdcOhcmlvcyByZXNwb25zw6F2ZWlzIHBlbGEgYXRyaWJ1acOnw6NvIGRlIGF1dG9yaWEgZSBtYW51dGVuw6fDo28KZGEgaW50ZWdyaWRhZGUgZGEgT0JSQSBlbSBxdWFscXVlciB1dGlsaXphw6fDo28uCgpBIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaCnJlc3BlaXRhIG9zIGNvbnRyYXRvcyBlIGFjb3Jkb3MgcHJlZXhpc3RlbnRlcyBkb3MgQXV0b3JlcyBjb20gdGVyY2Vpcm9zLCBjYWJlbmRvIGFvcyBBdXRvcmVzCmluZm9ybWFyIMOgIEluc3RpdHVpw6fDo28gYXMgY29uZGnDp8O1ZXMgZSBvdXRyYXMgcmVzdHJpw6fDtWVzIGltcG9zdGFzIHBvciBlc3RlcyBpbnN0cnVtZW50b3MuCg==Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-30T12:34:46Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
title Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
spellingShingle Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
Oliveira, Ueriton Dias de
Vírus Linfotrópico T Tipo 1 Humano
Antígenos
Plasma
Infecção
Gestantes
Human Type 1 T Lymphotropic Virus
Antigens
Plasma
Infection
Pregnants
title_short Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
title_full Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
title_fullStr Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
title_full_unstemmed Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
title_sort Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients
author Oliveira, Ueriton Dias de
author_facet Oliveira, Ueriton Dias de
Santos, Fred Luciano Neves
Castro Filho, Bernardo Galvão
Krieger, Marco Aurelio
Zanchin, Nilson Ivo Tonin
author_role author
author2 Santos, Fred Luciano Neves
Castro Filho, Bernardo Galvão
Krieger, Marco Aurelio
Zanchin, Nilson Ivo Tonin
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Ueriton Dias de
Santos, Fred Luciano Neves
Castro Filho, Bernardo Galvão
Krieger, Marco Aurelio
Zanchin, Nilson Ivo Tonin
dc.subject.other.pt_BR.fl_str_mv Vírus Linfotrópico T Tipo 1 Humano
Antígenos
Plasma
Infecção
Gestantes
topic Vírus Linfotrópico T Tipo 1 Humano
Antígenos
Plasma
Infecção
Gestantes
Human Type 1 T Lymphotropic Virus
Antigens
Plasma
Infection
Pregnants
dc.subject.en.pt_BR.fl_str_mv Human Type 1 T Lymphotropic Virus
Antigens
Plasma
Infection
Pregnants
description FIOCRUZ Technical Platform program through the Platforms for Protein Purification and Characterization and Proteomics at the Carlos Chagas Institute. This study benefited from FINEP (grant agreement 01.11.0286.00) and BNDES (grant agreement 11.2.1328.1) funding. Nilson I. T. Zanchin is a CNPq research fellow (grants nr. 312195/2015-0 and 304167/2019-3).
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-03-22T17:38:58Z
dc.date.available.fl_str_mv 2021-03-22T17:38:58Z
dc.date.issued.fl_str_mv 2021
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv OLIVEIRA, Ueriton Dias de et al. Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients. Journal of Clinical Microbiology, p. 1-43, Jan. 2021.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/46391
dc.identifier.issn.pt_BR.fl_str_mv 0095-1137
dc.identifier.doi.none.fl_str_mv 10.1128/JCM.02701-20
identifier_str_mv OLIVEIRA, Ueriton Dias de et al. Novel genetic 1 constructs for production of recombinant HTLV-1/2 antigens and 2 evaluation of their reactivity to plasma samples from HTLV1-infected patients. Journal of Clinical Microbiology, p. 1-43, Jan. 2021.
0095-1137
10.1128/JCM.02701-20
url https://www.arca.fiocruz.br/handle/icict/46391
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/46391/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/46391/2/Oliveira%2c%20Ueriton%20Dias%20Novel%20genetic....pdf
https://www.arca.fiocruz.br/bitstream/icict/46391/3/Oliveira%2c%20Ueriton%20Dias%20Novel%20genetic....pdf.txt
bitstream.checksum.fl_str_mv 36b51ef91c52b5338d9d29ba0cc807bc
986a4a5bae46c16ad9f36c3a7200f1e1
8584e6b5bbb5d764cb598dd52cec0cc5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009133618593792